Compass Pathways
CMPS11.5706.15% ( +0.670 )
Compass Pathways (CMPS)
COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360...
- Open
- 10.920
- High
- 11.600
- Low
- 10.830
- Prev. Close
- 10.900
- Volume
- 1.97M
- Turnover
- 22.20M
- Avg Price
- 11.274
- Bid/Ask Ratio
- --
- Amplitude
- 7.06%
- 52wk High
- 15.400
- Volume Ratio
- 0.69
- Turnover Ratio
- 1.82%
Compass Pathways Analyst Rating
View MoreForecast & Rating
Jul 27, 2026Price forecast
$23.75105.27%
Forecast & RatingStrong buy
16analysts
- Strong buy75.00%
- Buy18.75%
- Hold6.25%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 05:31 AM
Compass Pathways to report Q2, first-half results, host conference call
- Global Report · Jul 21 at 04:13 AM
Industrial Mega-Deals and Retail Restructurings Highlight Divergent 2026 Paths
- Global Report · Jul 18 at 04:13 AM
M&A, AI Drug Discovery, and Late-Stage Clinical Readouts Define US Biotech Q2 Trajectory
- MSN · Jul 16 at 06:13 AM
At a glance: Stocks gapping up premarket
- Global Report · Jul 15 at 04:13 AM
Navigating the 2026 Economy: How AI and Resource Scarcity Are Rewiring Corporate Strategy
- benzinga_article · Jul 9 at 12:35 PM
9 Health Care Stocks With Whale Alerts In Today’s Session
